Skip to main content

Why it's critical for Primary Care First participants to control and understand leakage

Patients' primary care visits outside of their attributed primary care office, also called “leaked” patient visits, can have unintended consequences for Primary Care First participants. Beginning July 2022, PCF Cohort 1 will face a reduction in population-based payments based on their leakage rate. The payment adjustment will be based on their 2021 claims data and will roll forward quarterly.

To calculate your leakage rate, divide the number of qualifying visits and services your attributed beneficiaries have made to care centers outside of your practice (for example, visits to urgent care centers) by the total number of qualifying visits and services your attributed beneficiaries have made.

Calculating primary care leakage with claims data alone comes with some unintended challenges. Unfortunately, some circumstances can unfairly and negatively impact a practice’s leakage rate:

  1. Nuances classifying care delivered by provider team members: It’s difficult to distinguish if certain types of providers are providing primary care alone based on their primary National Plan & Provider Enumeration System taxonomy code. Therefore, CMS determined that visits to a physician assistant will not count toward leakage. However, we believe additional revisions to this definition are needed to accurately exclude specialty care services from counting toward leakage when care is delivered by nurse practitioners. 
  2. Observation stays can inadvertently be captured as leakage: CMS should implement an exclusion for encounters delivered in the outpatient hospital setting to avoid observation stays from potentially counting toward a practice’s leakage rate. 
  3. Flawed definition of a practice: CMS currently defines a practice in the PCF program by Tax Identification Number and physical location. This means that if a primary care practice spans multiple floors within a building or uses coverage circles, each location is treated as a separate and distinct practice. Any visits between these locations will therefore contribute to the leakage rate. By expanding the definition of a practice, organizations would not be penalized in these circumstances.

Given the gray areas in determining leakage, PCF participants should closely monitor their leakage rates and visits that could be considered leakage. Monitoring and evaluating claims data will be critical for practices to drill down into why leaked visits occur, including identifying where patients are going and which services they receive when they go to external practices. This information will enable practices to implement changes to support patient retention.

By keeping an eye on leaked visits, providers can experience clinical benefits as well. Since leakage can cause non-coordinated fragmented care and limit provider visibility into patient history and medical records, high leakage increases risk for unnecessary utilization and misdiagnosis.

Going forward, practices and supporting stakeholders must advocate for specific methodological revisions to the leakage calculation for a fairer application of the payment adjustment so the program remains fiscally viable for participants.

Need support in accurately evaluating and monitoring performance data to assess your practice’s leakage? Contact DataGen today to learn how you can determine which patients are leaking through, which providers they're seeing and what services they are receiving. 


Popular posts from this blog

BPCI Advanced – take advantage of the model extension now

The Bundled Payment for Care Improvement (BPCI) Advanced Model is now open for applications until May 31, 2023. This model provides a unique opportunity to acute care hospitals and physician group practices who are looking to: evaluate their bundle performance; rejoin if they have previously dropped out due to being under a convener; or take advantage of the changes to the model. With a small window to sign the participation agreement, you’ll need experts to process data quickly and accurately for evaluation. BPCI Advanced Program Details The Centers for Medicare & Medicaid Services (CMS) announced in October 2022 that this program will extend from January 2024 to December 2025. Data used for evaluation will be taken from the baseline period between October 2018 and September 2022. A participation agreement will be sent out in September 2023 and needs to be signed by October 2023 in order to participate. Those who apply before the May 31 deadline will benefit

BPCI Advanced Model Extension

CMS recently made several major announcements about the Bundled Payments for Care Improvement Advanced Model.  The model, which was due to expire at the end of 2023 (Model Year 6), will be extended for an additional two years through Dec. 31, 2025.  New applications will be accepted in 2023 for the two-year extension. Participants still active in Model Year 6 can continue without reapplying by signing an amended and restated participation agreement for Model Year 7.  New methodological changes will be implemented for Model Year 6, which starts on Jan. 1, 2023. Methodological changes include that: the CMS Discount Factor for medical clinical episodes will be reduced from 3% to 2%;  the Peer Group Trend Factor Adjustment cap for all clinical episodes will be reduced from 10% to 5%; the Major Joint Replacement of the Upper Extremity clinical episode category will become a multi-setting episode category by allowing episodes to be triggered when the procedure is performed in the hospital ou

You’ve been accepted to the Enhancing Oncology Model. Now what?

The Centers for Medicare and Medicaid Services Innovation Center recently announced approved applicants for the new Enhancing Oncology Model. If your facility has been selected by CMS, are you still weighing your options during the current baseline evaluation period?  Two deciding factors may include the program data that CMS provides and whether EOM is enough of an improvement over the prior Oncology Care Model to make your investment worthwhile. Another factor to consider: Will you have the resources in place to conduct a baseline evaluation before EOM’s program start on July 1, 2023? How EOM differs from OCM EOM aims to improve the coordination of oncology care, drive practice transformation and reduce Medicare fee-for-service spending through episode-based payment. It includes three major updates: Fewer cancer types. Compared with OCM’s 21, EOM will be limited to seven common cancer types: breast, prostate, lung, small intestine/colorectal, multiple myeloma, lymphoma and chronic le